Last reviewed · How we verify

NCT06845397: CHIP

Chuvashia Inappropriate Prescribing Study

Completed Last updated 10 June 2025
What this trial tests

trial in Multimorbidity, Cardiovascular Diseases in 300 participants. Completed in 7 August 2024.

Timeline
12 December 2023
Primary endpoint
7 August 2024
7 August 2024

Quick facts

Lead sponsorNational Medical Research Center for Therapy and Preventive Medicine
StatusCompleted
Study typeOBSERVATIONAL
Enrollment300
Start date12 December 2023
Primary completion7 August 2024
Estimated completion7 August 2024
Sites1 location across Russia

Conditions studied

Sponsor

National Medical Research Center for Therapy and Preventive Medicine

Who can join

50 and older, any sex, with Multimorbidity, Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a cross-sectional study based on an outpatient registry. All medical therapy will be registered in order to assess inappropriate prescribing's, in accordance with the criteria PROMPT and BEERS, also in accordance with the officially approved instructions for the use of this medicinal product.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other National Medical Research Center for Therapy and Preventive Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06845397.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing